Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-59,399
Closed -$3.29M 628
2017
Q2
$3.29M Buy
+59,399
New +$3.09M 0.34% 100
2017
Q1
Sell
-209,106
Closed -$10.4M 1068
2016
Q4
$10.4M Buy
+209,106
New +$10.6M 0.6% 27
2016
Q3
Sell
-23,264
Closed -$1.04M 1093
2016
Q2
$1.04M Buy
23,264
+7,348
+46% +$319K 0.05% 468
2016
Q1
$651K Buy
+15,916
New +$586K 0.04% 548
2014
Q4
Sell
-6,071
Closed -$215K 582
2014
Q3
$215K Buy
+6,071
New +$226K 0.09% 331
2014
Q2
Sell
-9,319
Closed -$339K 444
2014
Q1
$339K Buy
+9,319
New +$340K 0.13% 245

Other funds holding XYL

Clinton Group's XYL Position: Q3 2017 in Review

Clinton Group sold out of Xylem (XYL) in Q3 2017, closing a stake of 59,399 shares — an estimated $3.29M sold.

Clinton Group first reported a position in XYL in Q1 2014 and held it in 6 quarters. The position peaked at $10.4M in Q4 2016. 573 funds tracked by Wall St. Rank hold XYL as of Q3 2017.

  • Clinton Group reported no remaining Xylem position as of Q3 2017 after selling out during the quarter.
  • Clinton Group sold 59,399 Xylem shares in Q3 2017, an estimated $3.29M.
  • Clinton Group first reported a position in Xylem in Q1 2014 and held it in 6 quarters.
  • Clinton Group's Xylem position peaked at $10.4M in Q4 2016.
  • 573 funds tracked by Wall St. Rank held Xylem as of Q3 2017.

Based on Clinton Group's 13F filing for Q3 2017, filed 14 Nov 2017.